1,400
Participants
Start Date
October 29, 2016
Primary Completion Date
January 30, 2021
Study Completion Date
April 28, 2026
Florbetapir F 18 PET Scan
Florbetapir F 18 positron emission tomography (PET) scan performed at baseline to confirm amyloid status. Participants who previously tested amyloid positive were exempt. No therapeutic investigational drug(s) intended to treat AD will be administered.
Healthwise Medical Associates, PC, Brooklyn
Integrative Clinical Trials, LLC, Brooklyn
Mid Hudson Medical Research, PLLC, New Windsor
Adirondack Medical Center, Lake Placid
Thomas Jefferson University, Philadelphia
St. Agnes Medical Group, Catonsville
Onsite Clinical Solutions, LLC, Charlotte
Onsite Clinical Solutions, LLC, Charlotte
Alzheimer's Memory Center, Charlotte
Coastal Carolina Healthcare, P.A., New Bern
Doctors Clinical Research, Atlanta
Jacksonville Center for Clinical Research, Jacksonville
Universal Neurological Care, Jacksonville
Sarkis Clinical Trials, Gainesville
Medical Research Group of Central Florida, Orange City
Combined Research Orlando Phase I-IV LLC, Orlando
Indago Research & Health Center, Inc., Hialeah
New Life Medical Research Center, Inc, Hialeah
Galiz Research, Hialeah
South Florida Clinical Trials, Hialeah
Empire Clinical Research, Miami Lakes
Van Buren Medical, Hollywood
Clinical Research of Homestead, Homestead
Infinite Clinical Research, Doral
Biomed Research Institute, Miami
Clinical Research of South Florida, Coral Gables
Miami Jewish Health Systems, Miami
International Research Partners, LLC., Doral
Florida International Research Center, Miami
The Neurology Research Group, LLC, Miami
Visionary Investigators Network, Aventura
L&C Professional Medical Research Institute, Miami
Sunrise Medical Research, Lauderdale Lakes
JEM Research Institute, Atlantis
Stedman Clinical Trials, Tampa
Suncoast Neuroscience Associates, St. Petersburg
Research Alliance, Clearwater
Asclepes Research Centers Florida, Weeki Wachee
Clinical Research Solutions, P.C., Knoxville
Wesley Neurology Clinic, Cordova
University of Mississippi Medical Center, Jackson
Hattiesburg Clinic, Hattiesburg
Baptist Health Medical Group, Lexington
Family Practice Center of Wooster, Wooster
Christ Hospital, Cincinnati
Dayton Center for Neurological Disorders, Centerville
American Health Network, Franklin
American Research, LLC, Jeffersonville
Psych Care Consultants Research, St Louis
Genoma Research Group, Inc., Miami
Heartland Research Associates, Newton
NeuroMedical Clinic of Central Louisiana, Alexandria
Lynn Health Science Institute, Oklahoma City
Lakeside Life Center, Carrollton
The Clinical Research Group, Frisco
North Pointe Psychiatry, Lewisville
University Hills Clinical Research, Irving
Univ Of Texas Southwestern at Dallas Childrens Med Ctr, Dallas
Dallas Clinical Research, Greenville
Highlands Medical Associates, P.A., Highlands
Colorado Neurological Institute, Englewood
Pacific Clinical Studies, Inc, Los Alamitos
Havana Research Institute, Pasadena
California Neurological Services, Inc., Panorama City
Sun Valley Research Center, Imperial
Breakthrough Clinical Trials, San Bernardino
Clinical Innovations, Inc., Riverside
Global Clinical Trials, Irvine
Irvine Clinical Research Center, Irvine
Alliance Research Centers, Laguna Hills
HB Clinical Trials, Santa Ana
California Pharmaceutical Research Institute, Anaheim
Advanced Research Center, Anaheim
Ventura Clinical Trials, Ventura
Premier Clinical Research, Spokane
Coastal Connecticut Research, LLC, New London
Pyramid Clinical Research, Monroe
Eli Lilly and Company
INDUSTRY